TSST-1 induces Th1 or Th2 differentiation in naïve CD4+ T cells in a dose- and APC-dependent manner

Scandinavian Journal of Immunology

Volumn 56, Issue 6, 2002, Pages 572-579

  Brandt, K ^a   Van der Bosch, J ^a   Fliegert, R ^a   Gehring, S ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXIS; CD4 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; TOXIC SHOCK SYNDROME TOXIN 1;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TOXIC SHOCK SYNDROME;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BACTERIAL TOXINS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROTOXINS; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; SUPERANTIGENS; TH1 CELLS; TH2 CELLS;

EID: 0036457072     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01170.x     Document Type: Article

References (32)

1. Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993;54:99-166.
2. Rink L, Luhm J, Koester M, Kirchner H. Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation. J Interferon Cytokine Res 1996;16:41-7.
3. Shands KN, Schmid GP, Dan BB et al. Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 1980;303:1436-42.
4. Freedman JD, Beer DJ. Expanding perspectives on the toxic shock syndrome. Adv Intern Med 1991;36:363-97.
5. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-11.
6. Choi Y, Lafferty JA, Clements JR et al. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 1990;172:981-4.
7. Gehring S, Schlaak M, van der Bosch J. A new in vitro model for studying human T cell differentiation: T(H1)/T(H2) induction following activation by superantigens. J Immunol Methods 1998;219:85-98.
8. Cameron SB, Nawijn MC, Kum WW, Savelkoul HF, Chow AW. Regulation of helper T cell responses to staphylococcal superantigens. Eur Cytokine Netw 2001;12:210-22.
9. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-30.
10. Bunikowski R, Mielke ME, Skarabis H et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105:814-9.
11. Leung DY, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993;92:1374-80.
12. + lymphocytes from children with atopic dermatitis contain an increased percentage of cells bearing staphylococcal-related T-cell receptor variable segments. Clin Exp Allergy 1998;28:1264-72.
13. Davison S, Allen M, Vaughan R, Barker J. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vβ-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000;121:181-6.
14. van der Bosch J, Ruller S, Horn D, Schumann R, Schlaak M. Density-dependent tumor cell death and reversible cell cycle arrest: Mutually exclusive modes of monocyte-mediated growth control. Exp Cell Res 1990;187:185-92.
15. + T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J Immunol 1992;148:1993-8.
16. + T cells. J Exp Med 1995;182:1591-6.
17. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995;181:1081-9.
18. Carballido JM, Carballido-Perrig N, Terres G, Heusser CH, Blaser K. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: Cytokine patterns change in response to the antigen concentration. Eur J Immunol 1992;22:1357-63.
19. Weber AK, Wahn U, Renz H. Superantigen-induced T cell death by apoptosis: Analysis on a single cell level and effect of IFN-γ and IL-4 treatment. Int Arch Allergy Immunol 2000;121:215-23.
20. + T cells by antigenic peptides altered for TCR binding. J Immunol 1997;158:4237-44.
21. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM. Kinetic discrimination in T-cell activation. Proc Natl Acad Sci USA 1996;93:1401-5.
22. Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K, Azuma M. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol 1997;9:637-44.
23. Bachmann MF, Sebzda E, Kundig TM et al. T cell responses are governed by avidity and co-stimulatory thresholds. Eur J Immunol 1996;26:2017-22.
24. Ijichi S, Yamano Y, Osame M, Hall WW. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: Reciprocal presentation of superantigen on the surface of activated lymphocytes. Cell Immunol 1996;173:312-6.
25. Nisini R, Fattorossi A, Ferlini C, D'Amelio R. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation. Eur J Immunol 1996;26:797-803.
26. + T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J Immunol 2000;165:6908-14.
27. Delgado M, Sun W, Leceta J, Ganea D. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J Immunol 1999;163:4213-23.
28. + T lymphocytes into Th1/Th2 effectors. Vaccine 1998;16:1415-9.
29. Jirapongsananuruk O, Melamed I, Leung DY. Additive immuno-suppressive effects of 1,25-dihydroxyvitamin D3 and cortico-steroids on TH1, but not TH2, responses. J Allergy Clin Immunol 2000;106:981-5.
30. + lymphocytes. J Immunol 1997;158:5589-95.
31. Macphail S. Superantigens: Mechanisms by which they may induce, exacerbate and control autoimmune diseases. Int Rev Immunol 1999;18:141-80.
32. Schiffenbauer J, Soos J, Johnson H. The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 1998;19:117-20.